WS #10158
USTR launched a Section 301 investigation into Germany over pharmaceutical pricing, potentially impacting German pharma stocks.
US Section 301 Investigation into Germany
USTR launched a Section 301 investigation into Germany over pharmaceutical pricing, potentially impacting German pharma stocks.